aAdverse experiences: any adverse experiences at any visit during treatment sessions and 24 weeks will be monitored. The research team will review all trial protocols, monitor patient safety and investigate any adverse events. bPatients will be asked whether they have used other medication during the treatment. If they have used concomitant medications then the type and dose of medication taken by them will also be recorded in detail.
Abbreviations: 6MWT, Six-Minute Walk Test; BBS, Berg Balance Scale; PD, Parkinson’s disease; PDQ-39, Parkinson’s Disease Questionnaire-39; TUG, Timed Up and Go Test; UPDRS-III, Unified Parkinson’s Disease Rating Scale Motor Section.